Switch to
More onapp

How to use scorecard? Learn more

Dr Lalchandani Labs Ltd

DLCL
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹8 cr, stock is ranked 4,430
High RiskStock is 5.01x as volatile as Nifty
19.490.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹8 cr, stock is ranked 4,430
High RiskStock is 5.01x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
0.89
Dividend YieldDiv. Yield
Sector PESector PE
51.91
Sector PBSector PB
6.64
Sector Div YldSctr Div Yld
0.47%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Lalchandani Labs is a provider of diagnostic and related healthcare tests and services.

Financial TrendFinancial statements 

20212022202320249.7811.285.046.241.010.92-1.560.63
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnOct 4, 2024

Dr Lalchandani Labs Ltd - 541299 - Revised Financial Statement For The Half Year And Year Ended March 31, 2024 Pursuant To The Communication Made By Exchange Dated October 03, 2024 | Download

Dr Lalchandani Labs Ltd - 541299 - Revised Financial Statement For The Half Year And Year Ended March 31, 2024 Pursuant To The Communication Made By Exchange Dated October 03, 2024 | Download

AGM/EGM 
Announced OnOct 3, 2024

Dr Lalchandani Labs Ltd - 541299 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Download

Dr Lalchandani Labs Ltd - 541299 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Download

AGM/EGM 
Announced OnSep 30, 2024

Dr Lalchandani Labs Ltd - 541299 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Download

Dr Lalchandani Labs Ltd - 541299 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Download

See all events